SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.38-9.0%Nov 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JamesK7/16/2023 12:32:10 PM
   of 52153
 
BBIO has a conference call on Monday for their ATTR drug.

Some speculation on the internet about trial results. Not sure they'd have a conference call for clearly bad results.

That leaves...
A. Good results.
B. Mixed results that needs a conference call for the spin.

Drug had some positive trends at 12 months. It is also a better stabilizer than PFE's Tafamadis. It would seem odd if it didn't work. Something wrong with the trial itself I'd say if negative result.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News